Endothelial modulation of agonist-induced vasoconstriction in mesenteric microcirculation

Xin Jin, Yukiko Otonashi-Satoh, Yoshito Zamami, Toshihiro Koyama, Pengyuan Sun, Yoshihisa Kitamura, Hiromu Kawasaki

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

It is widely accepted that vascular endothelium regulates vasoconstriction via release of endothelium-derived relaxing factors (EDRF). The mesenteric circulation, which is the largest vascular bed, influences regulation of systemic blood pressure. However, the role of EDRF in the modulation of vascular tone in peripheral mesenteric circulation has not been extensively studied. Therefore, our recent studies investigated the role of the vascular endothelium in the regulation of methoxamine (α1-adrenoceptor agonist)-induced vasoconstriction and their age-related changes in rat mesenteric vascular beds. In mesenteric vascular beds with intact endothelium isolated from 8 week-old rats, the initial maximum vasoconstriction induced by continuous perfusion of methoxamine was time-dependently decreased during 3 hour-perfusion. Neither nitric oxide synthase inhibitor nor cyclooxygenase inhibitor altered this time-dependent reduction of methoxamine-induced vasoconstriction. Endothelium removal, K+-channel inhibitors and gap junction inhibitor significantly inhibited the time-dependent reduction of methoxamine-induced vasoconstriction. In the preparations with intact endothelium from 16 week-old rats, the time-dependent reduction of methoxamine-induced vasoconstriction disappeared. Furthermore, endothelium removal and treatment with cyclooxygenase inhibitor, thromboxane A2 receptor antagonist or superoxide dismutase mimetic significantly reduced the methoxamine-induced vasoconstriction in the preparations from 16 week-old rats. These findings suggest that vascular endothelium acts to depress methoxamine-induced vasoconstriction by releasing endothelium-derived hyperpolarizing factor (EDHF), and dysfunction in this endothelial modulation develops with ageing.

Original languageEnglish
Pages (from-to)723-728
Number of pages6
JournalYakugaku Zasshi
Volume130
Issue number5
DOIs
Publication statusPublished - May 2010

Fingerprint

Methoxamine
Microcirculation
Vasoconstriction
Endothelium
Blood Vessels
Vascular Endothelium
Splanchnic Circulation
Endothelium-Dependent Relaxing Factors
Cyclooxygenase Inhibitors
Perfusion
Prostaglandin H2 Receptors Thromboxane A2
Gap Junctions
Nitric Oxide Synthase
Adrenergic Receptors
Superoxide Dismutase
Blood Pressure

Keywords

  • Ageing
  • Agonist-induced vasoconstriction
  • Endothelium-derived hyperpolarizing factor
  • Mesenteric resistance artery

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Endothelial modulation of agonist-induced vasoconstriction in mesenteric microcirculation. / Jin, Xin; Otonashi-Satoh, Yukiko; Zamami, Yoshito; Koyama, Toshihiro; Sun, Pengyuan; Kitamura, Yoshihisa; Kawasaki, Hiromu.

In: Yakugaku Zasshi, Vol. 130, No. 5, 05.2010, p. 723-728.

Research output: Contribution to journalArticle

Jin, Xin ; Otonashi-Satoh, Yukiko ; Zamami, Yoshito ; Koyama, Toshihiro ; Sun, Pengyuan ; Kitamura, Yoshihisa ; Kawasaki, Hiromu. / Endothelial modulation of agonist-induced vasoconstriction in mesenteric microcirculation. In: Yakugaku Zasshi. 2010 ; Vol. 130, No. 5. pp. 723-728.
@article{c3214696a4374a67878f950b2994ba15,
title = "Endothelial modulation of agonist-induced vasoconstriction in mesenteric microcirculation",
abstract = "It is widely accepted that vascular endothelium regulates vasoconstriction via release of endothelium-derived relaxing factors (EDRF). The mesenteric circulation, which is the largest vascular bed, influences regulation of systemic blood pressure. However, the role of EDRF in the modulation of vascular tone in peripheral mesenteric circulation has not been extensively studied. Therefore, our recent studies investigated the role of the vascular endothelium in the regulation of methoxamine (α1-adrenoceptor agonist)-induced vasoconstriction and their age-related changes in rat mesenteric vascular beds. In mesenteric vascular beds with intact endothelium isolated from 8 week-old rats, the initial maximum vasoconstriction induced by continuous perfusion of methoxamine was time-dependently decreased during 3 hour-perfusion. Neither nitric oxide synthase inhibitor nor cyclooxygenase inhibitor altered this time-dependent reduction of methoxamine-induced vasoconstriction. Endothelium removal, K+-channel inhibitors and gap junction inhibitor significantly inhibited the time-dependent reduction of methoxamine-induced vasoconstriction. In the preparations with intact endothelium from 16 week-old rats, the time-dependent reduction of methoxamine-induced vasoconstriction disappeared. Furthermore, endothelium removal and treatment with cyclooxygenase inhibitor, thromboxane A2 receptor antagonist or superoxide dismutase mimetic significantly reduced the methoxamine-induced vasoconstriction in the preparations from 16 week-old rats. These findings suggest that vascular endothelium acts to depress methoxamine-induced vasoconstriction by releasing endothelium-derived hyperpolarizing factor (EDHF), and dysfunction in this endothelial modulation develops with ageing.",
keywords = "Ageing, Agonist-induced vasoconstriction, Endothelium-derived hyperpolarizing factor, Mesenteric resistance artery",
author = "Xin Jin and Yukiko Otonashi-Satoh and Yoshito Zamami and Toshihiro Koyama and Pengyuan Sun and Yoshihisa Kitamura and Hiromu Kawasaki",
year = "2010",
month = "5",
doi = "10.1248/yakushi.130.723",
language = "English",
volume = "130",
pages = "723--728",
journal = "Yakugaku Zasshi",
issn = "0031-6903",
publisher = "Pharmaceutical Society of Japan",
number = "5",

}

TY - JOUR

T1 - Endothelial modulation of agonist-induced vasoconstriction in mesenteric microcirculation

AU - Jin, Xin

AU - Otonashi-Satoh, Yukiko

AU - Zamami, Yoshito

AU - Koyama, Toshihiro

AU - Sun, Pengyuan

AU - Kitamura, Yoshihisa

AU - Kawasaki, Hiromu

PY - 2010/5

Y1 - 2010/5

N2 - It is widely accepted that vascular endothelium regulates vasoconstriction via release of endothelium-derived relaxing factors (EDRF). The mesenteric circulation, which is the largest vascular bed, influences regulation of systemic blood pressure. However, the role of EDRF in the modulation of vascular tone in peripheral mesenteric circulation has not been extensively studied. Therefore, our recent studies investigated the role of the vascular endothelium in the regulation of methoxamine (α1-adrenoceptor agonist)-induced vasoconstriction and their age-related changes in rat mesenteric vascular beds. In mesenteric vascular beds with intact endothelium isolated from 8 week-old rats, the initial maximum vasoconstriction induced by continuous perfusion of methoxamine was time-dependently decreased during 3 hour-perfusion. Neither nitric oxide synthase inhibitor nor cyclooxygenase inhibitor altered this time-dependent reduction of methoxamine-induced vasoconstriction. Endothelium removal, K+-channel inhibitors and gap junction inhibitor significantly inhibited the time-dependent reduction of methoxamine-induced vasoconstriction. In the preparations with intact endothelium from 16 week-old rats, the time-dependent reduction of methoxamine-induced vasoconstriction disappeared. Furthermore, endothelium removal and treatment with cyclooxygenase inhibitor, thromboxane A2 receptor antagonist or superoxide dismutase mimetic significantly reduced the methoxamine-induced vasoconstriction in the preparations from 16 week-old rats. These findings suggest that vascular endothelium acts to depress methoxamine-induced vasoconstriction by releasing endothelium-derived hyperpolarizing factor (EDHF), and dysfunction in this endothelial modulation develops with ageing.

AB - It is widely accepted that vascular endothelium regulates vasoconstriction via release of endothelium-derived relaxing factors (EDRF). The mesenteric circulation, which is the largest vascular bed, influences regulation of systemic blood pressure. However, the role of EDRF in the modulation of vascular tone in peripheral mesenteric circulation has not been extensively studied. Therefore, our recent studies investigated the role of the vascular endothelium in the regulation of methoxamine (α1-adrenoceptor agonist)-induced vasoconstriction and their age-related changes in rat mesenteric vascular beds. In mesenteric vascular beds with intact endothelium isolated from 8 week-old rats, the initial maximum vasoconstriction induced by continuous perfusion of methoxamine was time-dependently decreased during 3 hour-perfusion. Neither nitric oxide synthase inhibitor nor cyclooxygenase inhibitor altered this time-dependent reduction of methoxamine-induced vasoconstriction. Endothelium removal, K+-channel inhibitors and gap junction inhibitor significantly inhibited the time-dependent reduction of methoxamine-induced vasoconstriction. In the preparations with intact endothelium from 16 week-old rats, the time-dependent reduction of methoxamine-induced vasoconstriction disappeared. Furthermore, endothelium removal and treatment with cyclooxygenase inhibitor, thromboxane A2 receptor antagonist or superoxide dismutase mimetic significantly reduced the methoxamine-induced vasoconstriction in the preparations from 16 week-old rats. These findings suggest that vascular endothelium acts to depress methoxamine-induced vasoconstriction by releasing endothelium-derived hyperpolarizing factor (EDHF), and dysfunction in this endothelial modulation develops with ageing.

KW - Ageing

KW - Agonist-induced vasoconstriction

KW - Endothelium-derived hyperpolarizing factor

KW - Mesenteric resistance artery

UR - http://www.scopus.com/inward/record.url?scp=77951973783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951973783&partnerID=8YFLogxK

U2 - 10.1248/yakushi.130.723

DO - 10.1248/yakushi.130.723

M3 - Article

C2 - 20460871

AN - SCOPUS:77951973783

VL - 130

SP - 723

EP - 728

JO - Yakugaku Zasshi

JF - Yakugaku Zasshi

SN - 0031-6903

IS - 5

ER -